Dx & Vx Co Ltd 180400
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 180400 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 4,230.00–4,335.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 4,310.00 / KRW 4,350.00
- Market Cap
- KRW 130.24 Bil
- Volume/Avg
- 63,406 / 205,070
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.68
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Dx & Vx Co Ltd provides precision medical-based genome analysis technology and AI-based big data DB construction, and based on the accumulated infrastructure of various molecular diagnosis businesses.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 98
- Website
- http://www.dxvx.com
Comparables
Valuation
|
Metric
|
180400
|
314930
|
377740
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 18.09 |
Price/Book Value | 6.08 | 6.24 | 0.27 |
Price/Sales | 2.68 | 69.32 | 4.64 |
Price/Cash Flow | — | — | — |
Price/Earnings
180400
314930
377740
Financial Strength
|
Metric
|
180400
|
314930
|
377740
|
|---|---|---|---|
Quick Ratio | 0.35 | 33.73 | 39.35 |
Current Ratio | 0.50 | 35.00 | 42.26 |
Interest Coverage | −4.01 | −8,694.04 | −221.49 |
Quick Ratio
180400
314930
377740
Profitability
|
Metric
|
180400
|
314930
|
377740
|
|---|---|---|---|
Return on Assets (Normalized) | −17.98% | −2.51% | 1.38% |
Return on Equity (Normalized) | −55.91% | −2.56% | 1.49% |
Return on Invested Capital (Normalized) | −18.14% | −3.88% | 0.31% |
Return on Assets
180400
314930
377740
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Dphlczrhy | Dptn | $209.3 Bil | |
DHR
| Danaher Corp | Zcqjkpxly | Vjrkyx | $174.8 Bil | |
IQV
| IQVIA Holdings Inc | Mvljwktw | Vmxnrm | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Txvnzykhl | Ycbwvkl | $41.0 Bil | |
A
| Agilent Technologies Inc | Sbhczmkdkz | Zzxhm | $39.2 Bil | |
MTD
| Mettler-Toledo International Inc | Pjsbmtcpl | Ntbnfhb | $26.5 Bil | |
ICLR
| Icon PLC | Qbytrrgv | Knycyb | $25.2 Bil | |
ILMN
| Illumina Inc | Zmqrjzljw | Mdhtrw | $19.8 Bil | |
WAT
| Waters Corp | Wvqslflxd | Pvqts | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Ltxtqdvby | Djtgjm | $17.1 Bil |